Jacobs Levy Equity Management, Inc Selecta Biosciences Inc Transaction History

Jacobs Levy Equity Management, Inc

$24.7 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 16, 2023	SELL	$1.02 - $1.23 $388,444 - $468,418	-380,828 Reduced 92.14%	32,485 $34,000
Q2 2023 Aug 14, 2023	SELL	$1.04 - $1.4 $122,385 - $164,749	-117,678 Reduced 22.16%	413,313 $462,000
Q1 2023 May 15, 2023	SELL	$1.15 - $1.89 $201,370 - $330,948	-175,105 Reduced 24.8%	530,991 $738,000
Q4 2022 Feb 14, 2023	SELL	$0.96 - $1.6 $14,326 - $23,876	-14,923 Reduced 2.07%	706,096 $797,000
Q3 2022 Nov 15, 2022	SELL	$1.33 - $2.6 $279,796 - $546,969	-210,373 Reduced 22.59%	721,019 $1.18 Million
Q2 2022 Aug 15, 2022	SELL	$0.67 - $1.4 $120,183 - $251,130	-179,379 Reduced 16.15%	931,392 $1.22 Million
Q1 2022 May 16, 2022	SELL	$1.23 - $3.31 $804,117 - $2.16 Million	-653,754 Reduced 37.05%	1,110,771 $1.37 Million
Q4 2021 Feb 14, 2022	SELL	$2.89 - $4.43 $697,357 - $1.07 Million	-241,300 Reduced 12.03%	1,764,525 $5.75 Million
Q3 2021 Nov 15, 2021	SELL	$3.36 - $4.62 $720,091 - $990,126	-214,313 Reduced 9.65%	2,005,825 $8.34 Million
Q2 2021 Aug 16, 2021	BUY	$2.82 - $5.01 $392,386 - $697,111	139,144 Added 6.69%	2,220,138 $9.28 Million
Q1 2021 May 17, 2021	BUY	$2.92 - $5.07 $2.9 Million - $5.03 Million	991,449 Added 91.0%	2,080,994 $9.42 Million
Q4 2020 Feb 16, 2021	BUY	$1.64 - $3.42 $1.31 Million - $2.73 Million	797,442 Added 273.0%	1,089,545 $3.3 Million
Q3 2020 Nov 16, 2020	BUY	$2.18 - $2.84 $108,816 - $141,761	49,916 Added 20.61%	292,103 $724,000
Q2 2020 Aug 17, 2020	BUY	$1.83 - $4.06 $378,021 - $838,670	206,569 Added 579.96%	242,187 $688,000
Q1 2020 May 15, 2020	BUY	$1.5 - $4.52 $53,427 - $160,993	35,618 New	35,618 $86,000
Q1 2019 May 14, 2019	SELL	$1.47 - $3.06 $122,356 - $254,702	-83,236 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$2.66 - $15.93 $17,199 - $103,003	6,466 Added 8.42%	83,236 $221,000
Q3 2018 Nov 14, 2018	BUY	$12.07 - $16.0 $7,242 - $9,600	600 Added 0.79%	76,770 $1.19 Million
Q2 2018 Aug 14, 2018	BUY	$9.36 - $13.25 $712,951 - $1.01 Million	76,170 New	76,170 $1.01 Million

Others Institutions Holding SELB

# of Institutions

Shares Held

4.67M

Call Options Held

Put Options Held

View Full List

About SELECTA BIOSCIENCES INC

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

More about SELB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Account